InsidersTradesSigma
Follow the 圣诺生物 stock price and the full directors' dealings record of the company, a listed issuer based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 圣诺生物 has recorded 1 public disclosures. Market capitalisation: €5bn. The latest transaction was reported on 28 November 2022 (Sale). Among the most active insiders: 卢昌亮. All data is accessible without an account.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€170
1 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 12,172 of 29,062 companies
56.1
score / 100
Value39
Quality73
FCF yld0.7%
Earn yld3.2%
EV/EBITDA21.1x
ROE17%
Gross mgn58%
Net mgn21%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 November 2022
Acerca de 圣诺生物
圣诺生物 es una empresa del sector sanitario y farmacéutico, que cotiza en la Bolsa de Shanghái. Se centra en el desarrollo y la comercialización de productos biofarmacéuticos.